Space-Based Genome Research Market Report 2026

The space-based genome research market size has grown rapidly in recent years. It will grow from $1.28 billion in 2025 to $1.45 billion in 2026 at a compound annual growth rate (CAGR) of 13.3%. The growth in the historic period can be attributed to initial human spaceflight biological studies, development of space-compatible laboratory equipment, early genomic sequencing technologies, government-funded space research missions, collaboration between space agencies and research institutes.

The space-based genome research market size is expected to see rapid growth in the next few years. It will grow to $2.37 billion in 2030 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to increasing long-duration space missions, rising investments in space medicine research, expansion of commercial space laboratories, growing use of genomics in personalized medicine, advancements in miniaturized sequencing technologies. Major trends in the forecast period include increasing deployment of space-based genomic experiments, rising use of microgravity sequencing platforms, growing integration of ai in genomic analysis, expansion of space biology research missions, enhanced focus on astronaut health genomics.

Growing financial commitments to space exploration are significantly contributing to the expansion of the space-based genome research sector. These investments, made by both government bodies and private organizations, are intended to support space missions, technological advancements, and the development of infrastructure necessary for exploring outer space. As interest intensifies in deep space travel and satellite initiatives, budgets for space-related programs are increasing. This influx of funding supports the creation of essential systems that enable genetic research in extraterrestrial environments. Conducting experiments in space enhances our understanding of human biology and plays a vital role in advancing healthcare technologies tailored for space missions. For example, the Space Foundation, a U.S. based nonprofit dedicated to promoting the global space industry, reported in July 2024 that the worldwide space economy reached $570 billion in 2023, which marked an increase of 7.4 percent from the revised 2022 total of $531 billion. As a result, increased investment in space exploration is driving growth in the space-based genome research market.

Leading organizations involved in space genome research are prioritizing the development of innovative solutions like genetic research programs to advance biomedical science and maintain astronaut health during prolonged spaceflights. These initiatives aim to study DNA and gene function, particularly how space-specific conditions such as radiation and microgravity influence genetic stability and expression. A notable example occurred in September 2024 when the ISS National Laboratory, a U.S. government funded research facility, launched a five-month mission to the International Space Station. This mission supports various scientific inquiries including botanical studies, heart health investigations, and genetic research, all taking advantage of the station's unique microgravity environment. The goal is to yield discoveries that can enhance life both in space and on Earth.

In December 2023, the State of the African Diaspora (SOAD), a political organization based in Jamaica, joined forces with Spaceomix to undertake groundbreaking DNA sequencing projects in outer space. This collaboration is set to perform the first genomic sequencing beyond low Earth orbit, targeting regions such as the Moon and deep space. The goal is to push the boundaries of space-based genetic science, uncover new medical knowledge, and establish SOAD and Spaceomix as frontrunners in space biomedical research. Spaceomix, headquartered in Malta, specializes in genomics for space environments.

Major Companies operating in the space-based genome research market are The Boeing Company, Cedars-Sinai-Medical-Center, European Space Agency, Japan Aerospace Exploration Agency, Redwire Corporation, Axiom Space Inc., Fresh Gravity Inc., Nanoracks, ResearchSat, SpacePharma, Space Tango, LambdaVision, Orbit Genomics, GeneLab, BioServe, Yuri GmbH, Angiex Inc., Genes in Space, Celestial Immunity, SpaceOMIX

North America was the largest region in the space-based genome research market in 2025. The regions covered in the space-based genome research market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the space-based genome research market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The space-based genome research market consists of revenues earned by entities providing services such as gene expression analysis, bioinformatics, and molecular diagnostics. The market value includes the value of related goods sold by the service provider or included within the service offering. The space-based genome research market includes sales of portable DNA or RNA sequencers, space-compatible lab equipment, microfluidic devices, CRISPR-based gene-editing tools, and bioinformatics software. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.